Bio Saga Headlines

Bio Saga

Saturday, April 7, 2012

Opening for freshers

Dhathri Ayurveda Private Ltd houses branded consumer goods like Dhathri Hair care herbal oil, Dhathri fairness facepack, Dheedhi Shampoo etc and has evolved into an household name in the Ayurveda segment in a short span of 6 years. Dhathri, with its range of 25 ayurveda products and has won the trust of millions across the world. The products are prepared under stringent quality control and the ingredients sourced from traditional herbal gardens and untouched mountain range
Post : R and D Scientist
No of opening : 3
Experience : 0 to 5 years
Job Description :Following are the Openings with Dhathri Group for its R&D Department.
  • Research Associate- Stability Study - (1 Year Experience in Stability Analysis)
  • Pharmacology - (2Years related Experience in Ayurveda Field)
  • Jr.Scientist - Food & Drug Formaulation - (3Years Expereince in Capsule,Tablet,oinment and Food Formulation)
Educational Qualification : M.Sc - Bio-Chemistry, Botany
Location : Ernakulam
Contact Details :Executive Name : Jayesh.S.V
Contact Company : Dhathri Ayurveda Pvt Ltd
Address : 39/172,Adappilly Rd,
Ernakulam, Kerala,India 682030
Email Address :
Deadline : 30.04.12

Shantani is a research based Biotechnology company and leaders in the field of chemical proteomics. Shantani strives for continuous excellence in developing cutting-edge technologies to probe the biological systems and in generating information useful for the development of novel medicines. Shantani’s technologies are offered as services to drug discovery companies and are utilized internally to advance Shantani’s own drug discovery efforts. We are looking for a highly motivated candidate to join our efforts of value creation as “Research Associate”
Job Description :1. Developing novel protocols for biomolecular conjugation
2. Innovating affinity chromatography based protein separation methods
3. Continuously advancing methodologies for protein identification
4. Conducting protocol based experiments
5. Documenting experimental outcomes to finest details
Preferred Qualification :1. Appetite for high-quality scientific research
2. Four year undergraduate or a five year master’s degree in chemistry / Biochemistry
3. ‘Let’s learn, solve & have fun’ attitude
Application Procedure : Write why you think you should be considered for the position and send it to along with your Curricular-Vitae / Resume.
Close Date : April 30th 2012

Friday, April 6, 2012

ISS Sides With Illumina, Recommends Rejecting Roche

This is getting interesting every day! I love this Idea! sell a company but before selling it split or spin off as another company with a future technology (Illumina). After a few years again sell or get acquired!

Citing vast future potential, ISS has sided with Illumina in the gene-sequencing company’s fight to hold off a hostile bid from Roche Holding.
The proxy advisor says shareholders should vote the Illumina board back into service, and reject Roche’s slate because the offer probably undervalues the future of Illumina.
Roche last week raised its offer for Illumina to $51 a share from $44.50, and called it fair and full. But Illumina shares immediately went above $51, and some in the market have pointed to $60 as the number to get the deal done.
Illumina rejected the offer, citing a report that compared the company to Apple and Illumina’s products to iPads. The company has argued that Roche’s bid came just after Illumina’s own shares had cratered on a bad quarter and that the Swiss drug giant was making an opportunistic bid to get the future of medicine on the cheap.
ISS agrees with that assessment. In a report, the advisor questions Roche’s use of a valuation tied to Illumina’s earnings, even as Roche calls it a historically high offer.
“As healthy as the current business and cash flows are, no one— Roche or public market investors—is interested in buying Illumina for its earning potential in the next twelve months, or on the strength of its earnings history over the last twelve months,” ISS writes.
ISS also applauded the actions of Illumina’s board, saying it had properly resisted the bid. The report says Illumina’s move to speed up the annual meeting for a shareholder vote “suggest confidence in the integrity” of its own positions.
The annual meeting vote is in two weeks, meaning there is still time for more letters and enthusiastic comments before this comes to a boil. 

Life Science and Informatics

What is this?
is this a new industry?
or a old wine in a new bottle?

Well Life Sciences and Informatics can be anything form computational biology, all omes and omics, core bioinformatics to curation and literature mining, database creation, in the area of biology, chemistry , bio-chem space.

There are number of companies in India and bangalore is the forefront as a major bio-cluster with 20 to 30 companies in this sphere.

now how good are these companies doing?
how good are they in terms of the international markets and how profitable is their business?
what do they do?
their clients?

These are some interesting things that could be discussed in this blog page...

Tag It